Equity Overview
Price & Market Data
Price: $1.04
Daily Change: $0.00 / 0.00%
Daily Range: $0.944 - $1.10
Market Cap: $5,102,182
Daily Volume: 38,279
Performance Metrics
1 Week: 2.97%
1 Month: -9.57%
3 Months: -15.45%
6 Months: -32.47%
1 Year: -53.78%
YTD: -15.45%
Company Details
Employees: 52
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Sunshine Biopharma, Inc. operates as a pharmaceutical company that focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates through Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products segments. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; Adva-27a, a small chemotherapy molecule to treat pancreatic cancer; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, and anticonvulsant indications. Sunshine The company is based in Fort Lauderdale, Florida.